Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
BI
ProShares Ultra NASDAQ Biotechnology
BIB
Volume
8.33K
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
BI
BIB
BI
ProShares Ultra NASDAQ Biotechnology
BIB
News
·
Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index
AUM
N/A
Volume
8.33K
Yield
0.31%
Chart
Earnings
News
About
Dividends
Insider
Filings
Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index
Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: CMPS) revealed Friday that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective as of market open on Monday, Dec. 20. “We are proud to announce our addition to the esteemed Nasdaq Biotechnology Index,” George Goldsmith, CEO and founder of Compass Pathways said. “Our inclusion in this index enables us to reach new audiences as we continue to execute on our clinical development of our investigational COMP360 psilocybin therapy in hopes of addressing the most challenging ...
Benzinga · Dec 17, 2021
Take a Look at the Top-Performing Biotech ETFs YTD
The pandemic has triggered a race to introduce vaccines and treatment options, opening up investment opportunities in the biotech sector.
Zacks Investment Research · Oct 2, 2021
Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs
Investors could easily tap the bullish trend by considering a near-term long on the biotech sector.
Zacks Investment Research · Aug 26, 2021
5 Best Leveraged ETFs of Last Week
We highlight a few leveraged ETF areas that won last week.
Zacks Investment Research · Jun 14, 2021
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
BI
BIB
ProShares Ultra NASDAQ Biotechnology
Buy
Sell
Market
Limit
Soon
BIB
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any BIB yet.
Related Tickers
Earnings
Dividends
Last · Sep 23
Quarterly
Amount
$0.0830
Yield
0.21%
Annual
$0.23